Last reviewed · How we verify

Sinusitis — Treatment Landscape & Competitive Intelligence

Sinusitis (disease) competitive landscape: 10 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

10 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Sinusitis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

DrugGenericSponsorClassTargetLine of therapyFirst approval
Methocillin S CLOXACILLIN GSK cloxacillin 1974-01-01
Bactocill In Plastic Container OXACILLIN Apothecon Dual 3',5'-cyclic-AMP and -GMP phosphodiesterase 11A, Prostaglandin G/H synthase 1, Prostaglandin G/H synthase 2 1971-01-01
Minocycline Hydrochloride MINOCYCLINE Rempex Tetracycline-class Drug 1971-01-01
Vibramycin doxycycline Generic (originally Pfizer) Tetracycline antibiotic 72 kDa type IV collagenase, Stromelysin-1, Collagenase 3 1967-01-01
Unasyn AMPICILLIN Bristol-Myers Squibb Penicillin-class Antibacterial Transient receptor potential cation channel subfamily M member 4 1965-01-01
Abelcet AMPHOTERICIN B Astellas Pharma Lipid-based Polyene Antifungal [EPC] 1964-01-01
Demethylchlortetracycline DEMECLOCYCLINE Pfizer Tetracycline-class Antimicrobial Estrogen receptor beta 1960-01-01
Minocyclin Minocyclin University of Southern California 30S ribosomal protein S4, 30S ribosomal protein S9, Tetracycline resistance protein, class B
Metacillin meticillin Bristol-Myers Squibb meticillin
Meclan MECLOCYCLINE Johnson And Johnson meclocycline

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

  1. · 3 drugs in Sinusitis
  2. Bristol-Myers Squibb · 2 drugs in Sinusitis
  3. Astellas Pharma · 1 drug in Sinusitis
  4. Bulovka Hospital · 1 drug in Sinusitis
  5. GSK · 1 drug in Sinusitis
  6. Generic (originally Pfizer) · 1 drug in Sinusitis
  7. Johnson And Johnson · 1 drug in Sinusitis
  8. Pfizer · 1 drug in Sinusitis
  9. Rempex · 1 drug in Sinusitis
  10. University of Southern California · 1 drug in Sinusitis
  11. Apothecon · 1 drug in Sinusitis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Sinusitis:

Cite this brief

Drug Landscape (2026). Sinusitis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/sinusitis. Accessed 2026-06-10.

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing